Skip to main content

Cancer Victim Gains $289 Million in Roundup Litigation

Cancer Victim Gains $289 Million in Roundup Litigation

Cancer Victim Gains $289 Million in Roundup Litigation

Introduction

In a landmark judgment on August 10, a San Francisco jury awarded the groundskeeper $250 million in punitive damages and nearly $40 million in compensatory damages over his alleged cancer.

The plaintiff, who is nearing death, argued for about $412 million in punitive damages and $39 million in compensatory damages over allegations that Monsanto's Roundup weedkiller and Ranger Prov herbicides caused him non-Hodgkin's lymphoma (NHL) in 2014. The plaintiff's win serves as an example for millions struggling to prove their case against the agricultural giant. His case was the first to undergo trial among several hundred affected due to the weedkiller.

While Monsanto officials continue to deny Roundup's involvement in causing deadly cancer, a spokesperson expressed that they are planning to appeal the jury's decision and stand by the product's safety. Roundup lawsuits are consolidated as a part of multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation), which holds more than 2,200 lawsuits, presided over by Judge Vince Chhabria, in the U.S. District Court of  San Francisco.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.